It'd be hard for you to believe that a drug like Gleevec, which is a drug for cancers.
FORBES: Billionaire Patrick Soon-Shiong On Health Care, Obama
Scientists have also speculated that the kind of HDL "good cholesterol" made by a drug like torcetrapib might be dysfunctional.
Why There Will Never Be Another Drug Like Lipitor And a look at the story of the best-selling drug of all time, now drawing to a close.
Someone is making millions on black label treatments for MS. Many patients refuse to put their body in harms way by taking a chance on a drug like Gilenya.
"I think most physicians think it is unethical to take a drug like that and market it with only one cholesterol-lowering medicine, " says Richard Stein, a cardiologist at Beth Israel Medical Center.
The big debate about the drug is whether lowering cholesterol with Zetia is as good as using a higher dose of a statin drug like Lipitor, Zocor or AstraZeneca (nyse: AZN - news - people )'s Crestor.
Dr. WEINER: Around the world there are certainly many women who have been on tamoxifen for five years, have been off all therapy for a few years, and might consider going on a drug like letrozole or specifically letrozole based on these results.
The alternative was to develop a protein-based drug, like Erbitux, but the drug would have to be injected.
Obviously, drug companies like Pfizer, GlaxoSmithkline, and Eli Lilly cannot manufacture a drug-based vaccine that immunizes the body against suicidal behavior.
Mayo also believes that certain drug-like compounds can speed-up the destruction of the damaging proteins.
FORBES: Alzheimer's Care Could Well Devastate The US Economy
Analysts pointed to big drug firms like Pfizer, GlaxoSmithKline, and AstraZeneca as potential bidders.
And the drug looks like it will move into other markets for treating sleepy patients next year.
The Colombian government has successfully fought the drug cartels eliminating high level drug lords like Pablo Escobar.
CENTERFORSECURITYPOLICY: The FTA with Colombia: the political dimension
The alternative was to develop a protein-based drug, like Erbitux, but then patients would have to be injected.
There could be another battle ahead, which could have implication for cancer drug companies like Novartis and Eli Lilly.
That potential has drawn competition from big drug firms like Wyeth and Novartis.
Even the very rich ethical drug houses like Pfizer, Eli Lilly, Bristol Meyers and JNJ could show late foot.
New food products must endure the same costly testing for toxicity as drugs, but do not offer drug-like returns.
Information technology appeals to drug companies like Merck because it may improve their ability to pitch their products to doctors.
The single biggest issue for the industry are the failed Ph3 programmes for drug classes like CETP inhibitors and anti-amyloids.
FORBES: Are We The Problem? The Role Of Poor Decision-Making In Stifling Drug Development
Drug firms like Pfizer, GlaxoSmithKline and Novartis have yet to realize a new generation of big-selling medicines based on gene research.
That kind of margin compares favorably with drug giants like Pfizer, which are often vilified for charging too much for their drugs.
The apparent failure illustrates the problems for drug firms like Pfizer as they spend millions to license drugs developed by other companies.
Big drug firms like Wyeth, Elan and Eli Lilly have spent years pursuing drugs based on the theory of what causes Alzheimer's disease.
That kind of profit margin compares favorably to drug giants like Pfizer, who are often vilified for charging too much for their drugs.
There had been an attitude that they were immune to the kinds of regulatory pressures that hurt drug companies like Merck and GlaxoSmithKline.
FORBES: Boston Scientific Turnaround Expert Quits Before The Turnaround
Drug companies like to talk about experimental medicines with blockbuster potential.
These dates can be used to predict drug approvals like clockwork.
Although drug companies like to complain that they are in an innovation drought, there have been plenty of big, world-changing drugs introduced in the Facebook era.
This allows big drug companies like Pfizer , Merck , and GlaxoSmithKline to grow quickly on the back of billion-dollar drugs that they and they alone can manufacture.
应用推荐